Product Code: ETC5634696 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The cardiac marker testing market in Gambia is experiencing growth as the healthcare sector continues to develop and there is increasing awareness of heart disease. Cardiac markers are essential for diagnosing and monitoring heart conditions, particularly in emergency care settings. As healthcare services improve and medical diagnostics become more accessible, demand for cardiac marker testing is expected to rise.
The Gambia Cardiac Marker Testing Market is expanding as healthcare providers seek advanced diagnostic tools to detect cardiovascular diseases early. Cardiac marker tests are crucial for diagnosing heart attacks and other heart-related conditions, driving their adoption in Gambia`s healthcare sector.
The Cardiac Marker Testing Market in Gambia is hindered by limited healthcare infrastructure and access to advanced diagnostic technologies. The market is also affected by the high cost of cardiac marker testing kits and the lack of trained healthcare professionals to perform these tests, which limits their availability and adoption in the country.
As part of its healthcare improvement agenda, the Gambian government has prioritized diagnostic services, including cardiac marker testing. Policies focus on expanding access to advanced diagnostic tools through public-private partnerships. Subsidies on medical equipment imports and training programs for healthcare workers support the growth of this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Cardiac Marker Testing Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Gambia Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Gambia Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Gambia Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Gambia Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Gambia Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Gambia Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Gambia Cardiac Marker Testing Market Trends |
6 Gambia Cardiac Marker Testing Market Segmentations |
6.1 Gambia Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Gambia Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.3 Gambia Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Gambia Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Gambia Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Gambia Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Gambia Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Gambia Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Gambia Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Gambia Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Gambia Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Gambia Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Gambia Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Gambia Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Gambia Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Gambia Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Gambia Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Gambia Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Gambia Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Gambia Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Gambia Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Gambia Cardiac Marker Testing Market Export to Major Countries |
7.2 Gambia Cardiac Marker Testing Market Imports from Major Countries |
8 Gambia Cardiac Marker Testing Market Key Performance Indicators |
9 Gambia Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Gambia Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Gambia Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Gambia Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Gambia Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Gambia Cardiac Marker Testing Market - Competitive Landscape |
10.1 Gambia Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Gambia Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |